1.Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority Trial
Ji-Jung JUNG ; Jong-Ho CHEUN ; Soo-Yeon KIM ; Jiwon KOH ; Jai Min RYU ; Tae-Kyung YOO ; Hee-Chul SHIN ; Sung Gwe AHN ; Seho PARK ; Woosung LIM ; Sang-Eun NAM ; Min Ho PARK ; Ku Sang KIM ; Taewoo KANG ; Jeeyeon LEE ; Hyun Jo YOUN ; Yoo Seok KIM ; Chang Ik YOON ; Hong-Kyu KIM ; Hyeong-Gon MOON ; Wonshik HAN ; Nariya CHO ; Min Kyoon KIM ; Han-Byoel LEE
Journal of Breast Cancer 2024;27(1):61-71
Purpose:
Advances in chemotherapeutic and targeted agents have increased pathologic complete response (pCR) rates after neoadjuvant systemic therapy (NST). Vacuum-assisted biopsy (VAB) has been suggested to accurately evaluate pCR. This study aims to confirm the non-inferiority of the 5-year disease-free survival of patients who omitted breast surgery when predicted to have a pCR based on breast magnetic resonance imaging (MRI) and VAB after NST, compared with patients with a pCR who had undergone breast surgery in previous studies.
Methods
The Omission of breast surgery for PredicTed pCR patients wIth MRI and vacuumassisted bIopsy in breaST cancer after neoadjuvant systemic therapy (OPTIMIST) trial is a prospective, multicenter, single-arm, non-inferiority study enrolling in 17 tertiary care hospitals in the Republic of Korea. Eligible patients must have a clip marker placed in the tumor and meet the MRI criteria suggesting complete clinical response (post-NST MRI size ≤ 1 cm and lesion-to-background signal enhancement ratio ≤ 1.6) after NST. Patients will undergo VAB, and breast surgery will be omitted for those with no residual tumor. Axillary surgery can also be omitted if the patient was clinically node-negative before and after NST and met the stringent criteria of MRI size ≤ 0.5 cm. Survival and efficacy outcomes are evaluated over five years.Discussion: This study seeks to establish evidence for the safe omission of breast surgery in exceptional responders to NST while minimizing patient burden. The trial will address concerns about potential undertreatment due to false-negative results and recurrence as well as improved patient-reported quality of life issues from the omission of surgery. Successful completion of this trial may reshape clinical practice for certain breast cancer subtypes and lead to a safe and less invasive approach for selected patients.
2.Bilateral periareolar hyperpigmentation after augmentation mammoplasty: a case report and literature review
Eun-Jung YANG ; Sang-Soo LEE ; Bong-Kyoon CHOI ; Sung Ran HONG ; Young-Seok KIM
Archives of Aesthetic Plastic Surgery 2022;28(2):79-83
Complications arising from breast augmentation procedures are broadly categorized as either surgery-related or prosthesis-related. Many reports have described complications associated with breast augmentation. However, to date, periareolar post-inflammatory hyperpigmentation (PIH) after breast augmentation has not been reported. Herein, we report a case of PIH after augmentation mammoplasty using a silicone implant through the periareolar approach. A 35-year-old woman, who underwent bilateral breast augmentation using a periareolar approach, presented with bilateral periareolar tissue changes, with dark brown, irregular macules appearing 6 weeks postoperatively. Based on clinical symptoms and histological examination, the lesion was diagnosed as PIH. Topical hydroquinone and retinoic acid were applied for 8 weeks after the pigmentation appeared. After 6 months of observation, the pigmentation faded. To summarize, we report a case of pigmentation around the bilateral nipples after periareolar breast augmentation along with a literature review.
3.Validation of the 8th AJCC Cancer Staging System for Pancreas Neuroendocrine Tumors Using Korean Nationwide Surgery Database
Yunghun YOU ; Jin Young JANG ; Song Cheol KIM ; Yoo Seok YOON ; Joon Seong PARK ; Chol Kyoon CHO ; Sang Jae PARK ; Jae Do YANG ; Woo Jung LEE ; Tae Ho HONG ; Keun Soo AHN ; Chi Young JEONG ; Hyeon Kook LEE ; Seung Eun LEE ; Young Hoon ROH ; Hee Joon KIM ; Hongbeom KIM ; In Woong HAN
Cancer Research and Treatment 2019;51(4):1639-1652
PURPOSE: The 8th edition of the American Joint Committee on Cancer (AJCC) staging system for pancreatic neuroendocrine tumor (PNET) included several significant changes. We aim to evaluate this staging system compared to the 7th edition AJCC staging system and European Neuroendocrine Tumors Society (ENETS) system. MATERIALS AND METHODS: We used Korean nationwide surgery database (2000-2014). Of 972 patients who had undergone surgery for PNET, excluding patients diagnosed with ENETS/World Health Organization 2010 grade 3 (G3), only 472 patients with accurate stage were included. RESULTS: Poor discrimination in overall survival rate (OSR) was noted between AJCC 8th stage III and IV (p=0.180). The disease-free survival (DFS) curves of 8th AJCC classification were well separated between all stages. Compared with stage I, the hazard ratio of II, III, and IV was 3.808, 13.928, and 30.618, respectively (p=0.007, p < 0.001, and p < 0.001). The curves of OSR and DFS of certain prognostic group in AJCC 7th and ENETS overlapped. In ENETS staging system, no significant difference in DFS between stage IIB versus IIIA (p=0.909) and IIIA versus IIIB (p=0.291). In multivariable analysis, lymphovascular invasion (p=0.002), perineural invasion (p=0.003), and grade (p < 0.001) were identified as independent prognostic factors for DFS. CONCLUSION: This is the first large-scale validation of the AJCC 8th edition staging system for PNET. The revised 8th system provides better discrimination compared to that of the 7th edition and ENETS TNM system. This supports the clinical use of the system.
Classification
;
Discrimination (Psychology)
;
Disease-Free Survival
;
Humans
;
Joints
;
Neoplasm Staging
;
Neuroectodermal Tumors, Primitive
;
Neuroendocrine Tumors
;
Pancreas
;
Survival Rate
4.A Novel Heterozygous ANO3 Mutation with Basal Ganglia Dysfunction in a Patient with Adult-Onset Isolated Segmental Dystonia.
Han Soo YOO ; Hyunjoo LEE ; Seok Jong CHUNG ; Jin Sung LEE ; Sang Kyoon HONG ; Phil Hyu LEE ; Yun Joong KIM ; Young Ho SOHN ; Hae Won SHIN
Journal of Clinical Neurology 2018;14(4):596-597
No abstract available.
Basal Ganglia*
;
Dystonia*
;
Humans
5.Prevalence of Metabolic Syndrome in Patients with Schizophrenia in Korea: A Multicenter Nationwide Cross-Sectional Study.
Jung Sun LEE ; Jun Soo KWON ; Daeho KIM ; Sung Wan KIM ; Jae Jin KIM ; Jong Hoon KIM ; Hee Jung NAM ; Seunghyong RYU ; Il Ho PARK ; Suk Kyoon AN ; Hong Seok OH ; Seunghee WON ; Kanguk LEE ; Kyu Young LEE ; Seung Hwan LEE ; Yu Sang LEE ; Jung Seo YI ; Kyung Sue HONG ; Yeon Ho JOO
Psychiatry Investigation 2017;14(1):44-50
OBJECTIVE: We designed a nationwide study with limited exclusion criteria to investigate the prevalence of metabolic syndrome (MetS) in Korea and its relationship with antipsychotic medications. METHODS: This multicenter, cross-sectional, and observational study included patients diagnosed with schizophrenia or schizoaffective disorder. Sixteen hospitals enrolled 845 patients aged 18 to 65 years prescribed any antipsychotic medication between August 2011 and August 2013. MetS was diagnosed using the criteria of the modified Adult Treatment Panel III of the National Cholesterol Education Program with the Korean abdominal obesity definition (waist circumference ≥85 cm in women, ≥90 cm in men). RESULTS: The prevalence of MetS in all patients was 36.5% and was significantly higher in men than women (men, 40.8%; women, 32.2%) and was significantly correlated with age [odds ratio (OR) 1.02] and duration of illness (OR 1.03). The prevalence of MetS across antipsychotic drugs in the major monotherapy group was as follows: 18.8% for quetiapine, 22.0% for aripiprazole, 33.3% for both amisulpride and paliperidone, 34.0% for olanzapine, 35% for risperidone, 39.4% for haloperidol, and 44.7% for clozapine. CONCLUSION: The prevalence of MetS is very high in patients with schizophrenia or schizoaffective disorder. Screening and monitoring of MetS is also strongly recommended.
Adult
;
Antipsychotic Agents
;
Aripiprazole
;
Cholesterol
;
Clozapine
;
Cross-Sectional Studies*
;
Education
;
Female
;
Haloperidol
;
Humans
;
Korea*
;
Male
;
Mass Screening
;
Obesity, Abdominal
;
Observational Study
;
Paliperidone Palmitate
;
Prevalence*
;
Psychotic Disorders
;
Quetiapine Fumarate
;
Risperidone
;
Schizophrenia*
6.Interstitial Lung Change in Pre-radiation Therapy Computed Tomography Is a Risk Factor for Severe Radiation Pneumonitis.
Yun Hee LEE ; Yeon Sil KIM ; Sang Nam LEE ; Hyo Chun LEE ; Se Jin OH ; Seoung Joon KIM ; Young Kyoon KIM ; Dae Hee HAN ; Ie Ryung YOO ; Jin Hyung KANG ; Suk Hee HONG
Cancer Research and Treatment 2015;47(4):676-686
PURPOSE: We examined clinical and dosimetric factors as predictors of symptomatic radiation pneumonitis (RP) in lung cancer patients and evaluated the relationship between interstitial lung changes in the pre-radiotherapy (RT) computed tomography (CT) and symptomatic RP. MATERIALS AND METHODS: Medical records and dose volume histogram data of 60 lung cancer patients from August 2005 to July 2006 were analyzed. All patients were treated with three dimensional (3D) conformal RT of median 56.9 Gy. We assessed the association of symptomatic RP with clinical and dosimetric factors. RESULTS: With a median follow-up of 15.5 months (range, 6.1 to 40.9 months), Radiation Therapy Oncology Group grade > or = 2 RP was observed in 14 patients (23.3%). Five patients (8.3%) died from RP. The interstitial changes in the pre-RT chest CT, mean lung dose (MLD), and V30 significantly predicted RP in multivariable analysis (p=0.009, p < 0.001, and p < 0.001, respectively). MLD, V20, V30, and normal tissue complication probability normal tissue complication probability (NTCP) were associated with the RP grade but less so for grade 5 RP. The risk of RP grade > or = 2, > or = 3, or > or = 4 was higher in the patients with interstitial lung change (grade 2, 15.6% to 46.7%, p=0.03; grade 3, 4.4% to 40%, p=0.002; grade 4, 4.4% to 33.3%, p=0.008). Four of the grade 5 RP patients had diffuse interstitial change in pre-RT CT and received chemoradiotherapy. CONCLUSION: Our study identified diffuse interstitial disease as a significant clinical risk for RP, particularly fatal RP. We showed the usefulness of MLD, V20, V30, and NTCP in predicting the incidence and severity of RP.
Chemoradiotherapy
;
Follow-Up Studies
;
Humans
;
Incidence
;
Lung Diseases, Interstitial
;
Lung Neoplasms
;
Lung*
;
Medical Records
;
Radiation Pneumonitis*
;
Radiotherapy
;
Risk Factors*
;
Tomography, X-Ray Computed
7.Change of Psychological Characteristics after Joining the Army According to Internet Addiction Tendency in Young Male Army Recruits.
Hyun Mook KANG ; Hyun Soo KIM ; Hyun Sang CHO ; Suk Kyoon AN ; Byoung Hoon OH ; Kang Soo LEE ; Chang Hyung HONG ; Hwallip BAE ; So Dahm KOOK ; Sang Joon SON
Journal of the Korean Society of Biological Psychiatry 2013;20(3):86-90
OBJECTIVES: The aim of this study was to find out the psychological changes associated with internet addiction between before and after the military drill among the young male army recruits. METHODS: All 1091 participants were army recruits aged from 19 to 22 years who participated in the 5-week military drill. They were assessed with some self-reported questionnaires [Sociodemographic questionnaires, Young's Internet Addiction Scale (IAS), the State-Trait Anxiety Inventory (STAI), the Beck Depression Inventory (BDI), the Barratt Impulsiveness Scale (BIS), the Attention-Deficit/Hyperactivity Disorder Self-Rated Scale (ASRS)]. They were divided into two groups, One is the internet addiction tendency group and the other is non-addiction group according to the IAS score. And the severity of the internet addiction tendency, depression, anxiety and impulsiveness were evaluated by the IAS, the STAI, the BDI, the BIS, the ASRS before and after military drill. RESULTS: The result of the paired t-test shows that the IAS, the STAI, the BDI, the BIS, the ASRS scores decreased after military drill in both non-addiction group and internet addiction tendency group. The result of the repeated measures ANOVA shows that there is an interaction effect between the changes of ASRS-hyperactivity (F = 23.437, p < 0.001), ASRS-impulsiveness (F = 4.896, p = 0.027), BIS-total (F = 4.057, p = 0.044), BIS-motor impulsiveness (F = 13.609, p < 0.001) scores and groups. The result of the generalized estimating equation shows that internet addiction tendency is associated with ASRS-inattention (beta = 0.075, p < 0.001), ASRS-hyperactivity (beta = 0.092, p = 0.002), STAI-trait anxiety (beta = 0.046, p < 0.001), BIS-motor impulsiveness (beta = 0.119, p = 0.028). CONCLUSIONS: The results show that psychopathologies such as internet addiction tendency, depression, anxiety, impulsiveness may improve after military drill regardless of the groups. Internet addiction tendency may be related to the ASRS-inattention, ASRS-hyperactivity, STAI-trait anxiety, motor-impulsiveness. So these findings may be considered in the treatment of internet addiction in terms of the impulsiveness control.
Anxiety
;
Depression
;
Humans
;
Internet*
;
Male*
;
Military Personnel
8.Early Diagnosis and Management of Chronic Obstructive Pulmonary Disease.
Sei Won LEE ; Jee Hong YOO ; Myung Jae PARK ; Eun Kyung KIM ; Ho Il YOON ; Deog Kyeom KIM ; Chang Hoon LEE ; Yong Bum PARK ; Joo Hun PARK ; Yong Il HWANG ; Ki Suck JUNG ; Kwang Ha YOO ; Hye Yoon PARK ; Jae Seung LEE ; Jin Won HUH ; Yeon Mok OH ; Seong Yong LIM ; Ji Ye JUNG ; Young Sam KIM ; Hui Jung KIM ; Chin Kook RHEE ; Young Kyoon KIM ; Jin Woo KIM ; Hyoung Kyu YOON ; Sang Do LEE
Tuberculosis and Respiratory Diseases 2011;70(4):293-300
Chronic obstructive pulmonary disease (COPD) is a substantially under-diagnosed disorder, and the diagnosis is usually delayed until the disease is advanced. However, the benefit of early diagnosis is not yet clear, and there are no guidelines in Korea for doing early diagnosis. This review highlights several issues regarding early diagnosis of COPD. On the basis of several lines of evidence, early diagnosis seems quite necessary and beneficial to patients. Early diagnosis can be approached by several methods, but it should be confirmed by quality-controlled spirometry. Compared with its potential benefit, the adverse effects of spirometry or pharmacotherapy appear relatively small. Although it is difficult to evaluate the benefit of early diagnosis by well-designed trials, several lines of evidence suggest that we should try to diagnose and manage patients with COPD at early stages of the disease.
Early Diagnosis
;
Humans
;
Korea
;
Pulmonary Disease, Chronic Obstructive
;
Spirometry
9.Proposal of New Criteria for Assessing Respiratory Impairment.
Joo Hun PARK ; Jae Seung LEE ; Jin Won HUH ; Yeon Mok OH ; Sang Do LEE ; Sei Won LEE ; Ho Il YOON ; Deog Kyeom KIM ; Chang Hoon LEE ; Myung Jae PARK ; Eun Kyung KIM ; Yong Bum PARK ; Yong Il HWANG ; Ki Suck JUNG ; Hye Yoon PARK ; Seong Yong LIM ; Ji Ye JUNG ; Young Sam KIM ; Hui Jung KIM ; Chin Kook RHEE ; Hyoung Kyu YOON ; Young Kyoon KIM ; Jin Woo KIM ; Jee Hong YOO ; Kwang Ha YOO
Tuberculosis and Respiratory Diseases 2011;70(3):199-205
Social welfare services for respiratory-disabled persons in Korea are offered based on the respiratory impairment grade, which is determined by 3 clinical parameters; dyspnea, forced expiratory volume in 1 second (FEV1), and arterial oxygen tension. This grading system has several limitations in the objective assessment of respiratory impairment. We reviewed several guidelines for the evaluation of respiratory impairment and relevant articles. Then, we discussed a new grading system with respiratory physicians. Both researchers and respiratory physicians agreed that pulmonary function tests are essential in assessing the severity of respiratory impairment, forced vital capacity (FVC), FEV1 and single breath diffusing capacity (DLco) are the primarily recommended tests. In addition, we agreed that arterial blood gas analysis should be reserved for selected patients. In conclusion, we propose a new respiratory impairment grading system utilizing a combination FVC, FEV1 and DLco scores, with more social discussion included.
Blood Gas Analysis
;
Disability Evaluation
;
Dyspnea
;
Forced Expiratory Volume
;
Humans
;
Korea
;
Oxygen
;
Pulmonary Diffusing Capacity
;
Respiratory Function Tests
;
Respiratory System
;
Social Welfare
;
Spirometry
;
Vital Capacity
10.Determination of Malignant and Invasive Predictors in Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Suggested Scoring Formula.
Dae Wook HWANG ; Jin Young JANG ; Chang Sup LIM ; Seung Eun LEE ; Yoo Seok YOON ; Young Joon AHN ; Ho Seong HAN ; Sun Whe KIM ; Sang Geol KIM ; Young Kook YUN ; Seong Sik HAN ; Sang Jae PARK ; Tae Jin LIM ; Koo Jung KANG ; Mun Sup SIM ; Seong Ho CHOI ; Jin Seok HEO ; Dong Wook CHOI ; Kyung Yul HUR ; Dong Shik LEE ; Sung Su YUN ; Hong Jin KIM ; Chul Kyoon CHO ; Hyun Jong KIM ; Hee Chul YU ; Baik Hwan CHO ; In Sang SONG
Journal of Korean Medical Science 2011;26(6):740-746
Prediction of malignancy or invasiveness of branch duct type intraductal papillary mucinous neoplasm (Br-IPMN) is difficult, and proper treatment strategy has not been well established. The authors investigated the characteristics of Br-IPMN and explored its malignancy or invasiveness predicting factors to suggest a scoring formula for predicting pathologic results. From 1994 to 2008, 237 patients who were diagnosed as Br-IPMN at 11 tertiary referral centers in Korea were retrospectively reviewed. The patients' mean age was 63.1 +/- 9.2 yr. One hundred ninty-eight (83.5%) patients had nonmalignant IPMN (81 adenoma, 117 borderline atypia), and 39 (16.5%) had malignant IPMN (13 carcinoma in situ, 26 invasive carcinoma). Cyst size and mural nodule were malignancy determining factors by multivariate analysis. Elevated CEA, cyst size and mural nodule were factors determining invasiveness by multivariate analysis. Using the regression coefficient for significant predictors on multivariate analysis, we constructed a malignancy-predicting scoring formula: 22.4 (mural nodule [0 or 1]) + 0.5 (cyst size [mm]). In invasive IPMN, the formula was expressed as invasiveness-predicting score = 36.6 (mural nodule [0 or 1]) + 32.2 (elevated serum CEA [0 or 1]) + 0.6 (cyst size [mm]). Here we present a scoring formula for prediction of malignancy or invasiveness of Br-IPMN which can be used to determine a proper treatment strategy.
Adenocarcinoma, Mucinous/*pathology
;
Adult
;
Aged
;
Aged, 80 and over
;
Carcinoembryonic Antigen/blood
;
Carcinoma, Pancreatic Ductal/*pathology
;
Carcinoma, Papillary/*pathology
;
Female
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Neoplasm Invasiveness
;
Neoplasm Staging
;
Pancreatic Neoplasms/*pathology
;
Predictive Value of Tests
;
ROC Curve
;
Tomography, X-Ray Computed

Result Analysis
Print
Save
E-mail